StageZero Life Sciences Ltd T.SZLS

But the REAL news...

[gojotv!]

For "those with eyes to see and ears to hear..." as the good book says...
is that the reverse split won't happen. Even management decided against it.
And we all know that the main reason given for it was an uplisting to the NASDAQ... for which we need a higher share price.
And we all know that the main thing necessary to raise the share price is an increase in revenues...
And we all know that Rebecca called our eResearch analyst's revenue estimate of 17M for 2021 "conservative".
I'm clearly not the only one who can put together the pieces here, because the share price is rising.
GLTA!

[Bogeyfree1]

Rebecca? - 17M revenues? - REALLY? Tripp = CEO of the year (next year though). Reality = SP at ..48

[StockscoutX]

Only $17+ million for 2021? I was expecting much more. Furthermore, not really new news at AGM as much of what is known is already baked into the SP. Now, it's obvious why the AGM was scheduled on june 30 a day before the canadian stock markets are closed. Also, Tripp was barely voted as a director which there will be more of the same going forward. As for the reverse split 2:1, it was a wise

[LithLover]

$17 million at a multiple of 5-10 would suggest a market cap of $85-170 million.  Current market cap is $30 million.  3 to 5 times current share price.   So you are bashing $17 million when that would suggest a share price of of 3-5 times or $1.50-$2.50.    So you would expect much more revenue suggesting a share price well over $3.00  Gotcha.  You must be

[skiboard09]

Prob disappointed because Trip said when Covid started they had initial interest of 250k test which worked out to a much higher number. So why didn't they run as many tests then?  I think that is fair to wonder 

[brad129]

Past revenue isn't a true indicator of future revenue at this point, let's see if Aristotle will produce the revenue from declining Covid sales. At the high here in Ontario we are testing like 10-15 thousand a day compared to a high of 70-80 thousand. If our Covid drops at the same rate our revenue stream could be in jeopardy.

[IainCaimbeul]

LL -must shutup, you have nothing to offer, kitty cat.

[hilles]

And we all know that Rebecca called our eResearch analyst's revenue estimate of 17M for 2021 "conservative".  Can you tell me where did you get that information ? Hilles

[davewho]

are you asking for the research report? 2021 Revenue Estimate: US$16.7 million StageZero Aristotle® testing revenue commences in Q3/2021 StageZero closes the acquisition of the Health Clinics Companies in 2021 1-Year Forward Revenue Estimate: US$23.0 million Revenue Growth 2022E: 100% 2023E: 50% 2024E: 40

[hilles]

I am looking for the quote where Rebecca finds the 17 millions CONSERVATIVE.... Hilles

[Mykndrsn]

Ask her. You know how email works right?

[RexTL44]

This post has been removed in accordance with Community Policy

[gojotv!]

I was quoting an email Rebecca sent me in response to a query. I had posted it previously. Of course, anyone paying attention to incoming revenue streams would be compelled to agree. For one, deal with Oncore, largely suspended due to Covid, is probably going to resume soon, only they may choose to switch to Aristotle over ColonSentry alone... And the upcoming travel boom will create a huge uptick

[IainCaimbeul]

Gojotv! Congrats You have posted a comment without hyperbole, bombast, font size 16, or bold (shouting). You have 4 brief paragraphs, all reasonably presented. Para 1: will give you the benefit on the Becky email, although it is picking fly poop out of pepper - conservative? Para 2: revenue streams I agree Para 3: let's hope so Para4: covid testing, could be a cash cow for some time, but not a